ロード中...
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
Malignant melanoma, an aggressive form of skin cancer, has a low five-year survival rate in patients with advanced disease. Immunotherapy represents a promising approach to improve survival rates among patients at advanced stage. Herein, the aim of the study was to design and produce, by using engin...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8070801/ https://ncbi.nlm.nih.gov/pubmed/33919827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13040547 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|